机器人对比视频辅助肺叶/肺段切除术治疗肺癌的荟萃分析
该荟萃分析纳入14项研究共7438例患者,比较机器人辅助(RAL/S)与视频辅助(VAL/S)肺叶/肺段切除术的围术期结局。结果显示RAL/S组30天死亡率和中转开胸率显著更低,而术后并发症、手术时间、住院时间等指标两组相似。结论认为RAL/S是VAL/S可行且安全的替代方案。
要点
- RAL/S组30天死亡率(0.7% vs 1.1%)和中转开胸率(10.3% vs 11.9%)显著低于VAL/S组。
- 两组术后并发症、手术时间、住院时间、拔管时间及淋巴结获取情况均无显著差异。
- 累积荟萃分析提示两组相对效应已趋稳定,亚组分析与总体分析结果一致。
核心结论
- RAL/S是VAL/S用于肺癌根治性切除的可行且安全的替代方案。
- 未来研究应关注RAL/S的长期获益与成本效益。
研究设计与样本
- 荟萃分析,全面检索在线数据库,共纳入14项研究、7438例患者。
- RAL/S组3239例,VAL/S组4199例;进行累积荟萃分析及特定亚组分析(倾向性评分匹配研究、纯肺叶切除术研究)。
主要发现
- 30天死亡率RAL/S组0.7% vs VAL/S组1.1%,OR 0.53,P=0.045。
- 中转开胸率RAL/S组10.3% vs VAL/S组11.9%,OR 0.57,P<0.001。
- 术后并发症27.5% vs 28.2%,OR 0.95,P=0.431。
- 手术时间176.63 vs 162.74 min,SMD 0.30,P=0.086。
- 住院时间4.90 vs 5.23天,SMD -0.08,P=0.292;拔管时间4.10 vs 3.53天,SMD 0.25,P=0.120。
临床怎么用
- 在肺癌根治性切除中,RAL/S可作为VAL/S的替代选择,尤其关注降低30天死亡率和中转开胸率。
- 现有证据未显示RAL/S在并发症、手术时间、住院时间及淋巴结清扫方面优于VAL/S。
局限性
- 未来需进一步研究RAL/S的长期获益与成本效益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: : Objective: To compare the safety/efficacy of the robotic-assisted lobectomy/segmentectomy (RAL/S) with the video-assisted lobectomy/segmentectomy (VAL/S) for radical lung cancer resection. BACKGROUND: It remains uncertain whether the newly developed RAL/S is comparable with the VAL/S. METHODS: A comprehensive search of online databases was performed. Perioperative outcomes were synthesized. Cumulative meta-analysis was performed to evaluate the temporal trend of pooled outcomes. Specific subgroups (propensity score matching studies, pure lobectomy studies) were examined. RESULTS: Analysis of 14 studies including a total of 7438 patients was performed. RAL/S was performed on 3239 patients, whereas the other 4199 patients underwent VAL/S. The 30-day mortality [0.7% vs 1.1%; odds ratio (OR) 0.53, P = 0.045] and conversion rate to open surgery (10.3% vs 11.9%; OR 0.57, P < 0.001) were significantly lower in patients who underwent RAL/S than VAL/S. Meanwhile, the postoperative complications (27.5% vs 28.2%; OR 0.95, P = 0.431), operation time [176.63 vs 162.74 min; standardized mean difference (SMD) 0.30, P = 0.086], duration of hospitalization (4.90 vs 5.23 days; SMD -0.08, P = 0.292), days to tube removal (4.10 vs 3.53 days; SMD 0.25, P = 0.120), retrieved lymph node (11.96 vs 10.67; SMD 0.46, P = 0.381), and retrieved lymph node station (4.98 vs 4.32; SMD 0.83, P = 0.261) were similar between the 2 groups. The cumulative meta-analyses suggested that the relative effects between 2 groups have already stabilized. All outcomes of subgroup and overall analyses were similar. CONCLUSIONS: This up-to-date meta-analysis confirms that RAL/S is a feasible and safe alternative to VAL/S for radical resection of lung cancer. Future studies should focus on the long-term benefits and cost effectiveness of RAL/S compared with VAL/S.
引用
- Liang H, Liang W, Zhao L, et al. Robotic Versus Video-assisted Lobectomy/Segmentectomy for Lung Cancer: A Meta-analysis. Ann Surg. 2018. PMID: 28628562. doi:10.1097/SLA.0000000000002346
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。